학술논문

SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Document Type
Article
Author
Vogels, Chantal B.F.Watkins, Anne E.Harden, Christina A.Brackney, Doug E.Shafer, JaredWang, JianhuiCaraballo, CésarKalinich, Chaney C.Ott, Isabel M.Fauver, Joseph R.Kudo, ErikoLu, PeiwenVenkataraman, ArvindTokuyama, MariaMoore, Adam J.Muenker, M. CatherineCasanovas-Massana, ArnauFournier, JohnBermejo, SantosCampbell, MelissaDatta, RupakNelson, AllisonAnastasio, KellyAskenase, Michael H.Batsu, MariaBickerton, SeanBrower, KristinaBucklin, Molly L.Cahill, StaciCao, YiyunCourchaine, EdwardDeIuliis, GiuseppeEarnest, RebeccaGeng, BertieGoldman-Israelow, BenjaminHandoko, RyanKhoury-Hanold, WilliamKim, DanielKnaggs, LyndaKuang, MaxineLapidus, SarahLim, JosephLinehan, MelissaLu-Culligan, AliceMartin, AnjelicaMatos, IreneMcDonald, DavidMinasyan, MaksymNakahata, MauraNaushad, NidaNouws, JessicaObaid, AbeerOdio, CamilaOh, Ji EunOmer, SaadPark, AnnseaPark, Hong-JaiPeng, XiaohuaPetrone, MaryProphet, SarahRice, TylerRose, Kadi-AnnSewanan, LorenzoSharma, LokeshShaw, Albert C.Shepard, DeniseSmolgovsky, MikhailSonnert, NicoleStrong, YvetteTodeasa, CodrutaValdez, JordanVelazquez, SofiaVijayakumar, PavithraWhite, Elizabeth B.Yang, YexinDela Cruz, Charles S.Ko, Albert I.Iwasaki, AkikoKrumholz, Harlan M.Matheus, J.D.Hui, PeiLiu, ChenFarhadian, Shelli F.Sikka, RobbyWyllie, Anne L.Grubaugh, Nathan D.
Source
Med; March 2021, Vol. 2 Issue: 3 p263-280.e6
Subject
Language
ISSN
26666340
Abstract
Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to be plagued by assay costs and supply chain shortages. In response, we developed SalivaDirect, which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).